Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | HC toxin | 10607 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | HC toxin | 10607 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | HC toxin | 10607 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | HC toxin | 10607 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | HC toxin | 10607 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | cetirizine | 2678 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | cetirizine | 2678 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cetirizine | 2678 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | cetirizine | 2678 | drug-path |
| Asthma | R-HSA-444620 | map05310 | cetirizine | 2678 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | cetirizine | 2678 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | cetirizine | 2678 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | cetirizine | 2678 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cetirizine | 2678 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cetirizine | 2678 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | cetirizine | 2678 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | cetirizine | 2678 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | cetirizine | 2678 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | cetirizine | 2678 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | cetirizine | 2678 | drug-path |